These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17277201)

  • 1. Efficient synthesis of simvastatin by use of whole-cell biocatalysis.
    Xie X; Tang Y
    Appl Environ Microbiol; 2007 Apr; 73(7):2054-60. PubMed ID: 17277201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of lovastatin analogs with a broadly specific acyltransferase.
    Xie X; Watanabe K; Wojcicki WA; Wang CC; Tang Y
    Chem Biol; 2006 Nov; 13(11):1161-9. PubMed ID: 17113998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving simvastatin bioconversion in Escherichia coli by deletion of bioH.
    Xie X; Wong WW; Tang Y
    Metab Eng; 2007 Jul; 9(4):379-86. PubMed ID: 17625941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biosynthesis of simvastatin--a mini-review].
    Yang Z; Gan C
    Sheng Wu Gong Cheng Xue Bao; 2008 Mar; 24(3):349-54. PubMed ID: 18589807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational improvement of simvastatin synthase solubility in Escherichia coli leads to higher whole-cell biocatalytic activity.
    Xie X; Pashkov I; Gao X; Guerrero JL; Yeates TO; Tang Y
    Biotechnol Bioeng; 2009 Jan; 102(1):20-8. PubMed ID: 18988191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-step production of the simvastatin precursor monacolin J by engineering of an industrial strain of Aspergillus terreus.
    Huang X; Liang Y; Yang Y; Lu X
    Metab Eng; 2017 Jul; 42():109-114. PubMed ID: 28619444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed evolution and structural characterization of a simvastatin synthase.
    Gao X; Xie X; Pashkov I; Sawaya MR; Laidman J; Zhang W; Cacho R; Yeates TO; Tang Y
    Chem Biol; 2009 Oct; 16(10):1064-74. PubMed ID: 19875080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotechnological production and applications of statins.
    Barrios-González J; Miranda RU
    Appl Microbiol Biotechnol; 2010 Jan; 85(4):869-83. PubMed ID: 19820926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Single-Step Bioproduction of the Simvastatin Precursor Monacolin J in an Industrial Strain of Aspergillus terreus by Employing the Evolved Lovastatin Hydrolase.
    Liang B; Huang X; Teng Y; Liang Y; Yang Y; Zheng L; Lu X
    Biotechnol J; 2018 Jun; 13(6):e1800094. PubMed ID: 29637704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Saccharomyces cerevisiae for production of simvastatin.
    Bond CM; Tang Y
    Metab Eng; 2019 Jan; 51():1-8. PubMed ID: 30213650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into the catalytic mechanism of lovastatin hydrolase.
    Liang Y; Lu X
    J Biol Chem; 2020 Jan; 295(4):1047-1055. PubMed ID: 31839596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [One-step fermentation for producing simvastatin via RNAi silencing of lovF gene in Aspergillus terreus].
    Li N; Li M; Yu Z; Zhou J; Huang J
    Sheng Wu Gong Cheng Xue Bao; 2016 Apr; 32(4):478-486. PubMed ID: 28853269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of an Efficient and Robust Aspergillus terreus Cell Factory for Monacolin J Production.
    Huang X; Tang S; Zheng L; Teng Y; Yang Y; Zhu J; Lu X
    ACS Synth Biol; 2019 Apr; 8(4):818-825. PubMed ID: 30856313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly productive, whole-cell DERA chemoenzymatic process for production of key lactonized side-chain intermediates in statin synthesis.
    Ošlaj M; Cluzeau J; Orkić D; Kopitar G; Mrak P; Casar Z
    PLoS One; 2013; 8(5):e62250. PubMed ID: 23667462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Approaches Towards Antihypercholesterolemic Drug Simvastatin.
    Fattah TA; Saeed A; Shehzadi SA
    Curr Org Synth; 2019; 16(5):652-670. PubMed ID: 31984887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel anabolic agent: a simvastatin analogue without HMG-CoA reductase inhibitory activity.
    Hsieh KC; Kao CL; Feng CW; Wen ZH; Chang HF; Chuang SC; Wang GJ; Ho ML; Wu SM; Chang JK; Chen HT
    Org Lett; 2014 Sep; 16(17):4376-9. PubMed ID: 25115530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Substrate Scope of Acyltransferase LovD9 for the Biosynthesis of Statin Analogues.
    García-Marquina G; Núñez-Franco R; Grajales-Hernández D; Jiménez-Osés G; López-Gallego F
    Chemistry; 2023 Jul; 29(42):e202300911. PubMed ID: 37139626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin.
    Silva TD; Oliveira MA; de Oliveira RB; Vianna-Soares CD
    J Chromatogr Sci; 2012 Oct; 50(9):831-8. PubMed ID: 22689902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholesterol lowering properties of a complex compound simvastatin with glycyrrhizic acid (simvaglyzin) in experimental models].
    Vavilin VA; Salakhutdinov NF; Ragino IuI; Poliakov NE; Taraban MB; Leshina TV; Stakhneva EM; Liakhovich VV; Nikitin IuP; Tolstikov GA
    Biomed Khim; 2008; 54(3):301-13. PubMed ID: 18712086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.